| Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection P Cavalcante, B Galbardi, S Franzi, S Marcuzzo, C Barzago, S Bonanno, ... Immunobiology 221 (4), 516-527, 2016 | 60 | 2016 |
| Autophagy, inflammation and innate immunity in inflammatory myopathies C Cappelletti, B Galbardi, D Kapetis, G Vattemi, V Guglielmi, P Tonin, ... PLoS One 9 (11), e111490, 2014 | 49 | 2014 |
| Stimulus‐evoked potentials contribute to map the epileptogenic zone during stereo‐EEG presurgical monitoring D Boido, D Kapetis, V Gnatkovsky, C Pastori, B Galbardi, I Sartori, L Tassi, ... Human brain mapping 35 (9), 4267-4281, 2014 | 47 | 2014 |
| Network topology of NaV1. 7 mutations in sodium channel-related painful disorders D Kapetis, J Sassone, Y Yang, B Galbardi, MN Xenakis, RL Westra, ... BMC systems biology 11, 1-16, 2017 | 32 | 2017 |
| Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? P Cavalcante, S Marcuzzo, S Franzi, B Galbardi, L Maggi, T Motta, ... Oncotarget 8 (56), 95432, 2017 | 29 | 2017 |
| A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis S Marcuzzo, S Bonanno, M Figini, A Scotti, I Zucca, L Minati, N Riva, ... Experimental neurology 293, 43-52, 2017 | 23 | 2017 |
| Modulation of the estrogen/erbb2 receptors cross-talk by cdk4/6 inhibition triggers sustained senescence in estrogen receptor–and erbb2-positive breast cancer L Viganò, A Locatelli, A Ulisse, B Galbardi, M Dugo, D Tosi, C Tacchetti, ... Clinical Cancer Research 28 (10), 2167-2179, 2022 | 20 | 2022 |
| Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer C Guardia, G Bianchini, O Arpí-LLucià, S Menendez, D Casadevall, ... Clinical Cancer Research 27 (18), 5096-5108, 2021 | 18 | 2021 |
| Developmental dysfunction of the central nervous system lymphatics modulates the adaptive neuro-immune response in the perilesional cortex in a mouse model of traumatic brain … S Wojciechowski, A Virenque, M Vihma, B Galbardi, EJ Rooney, ... Frontiers in Immunology 11, 559810, 2021 | 18 | 2021 |
| Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab F Ligorio, S Di Cosimo, P Verderio, CM Ciniselli, S Pizzamiglio, ... JNCI: Journal of the National Cancer Institute 114 (12), 1720-1727, 2022 | 14 | 2022 |
| Aging‐associated genes and let‐7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy C Cappelletti, B Galbardi, M Bruttini, F Salerno, E Canioni, MB Pasanisi, ... The FASEB Journal 33 (6), 7155-7167, 2019 | 14 | 2019 |
| Variable electrobehavioral patterns during focal nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid S Arcieri, R Velotti, F Noè, G Carriero, A Cattalini, B Galbardi, ... Epilepsia 55 (12), 1978-1985, 2014 | 11 | 2014 |
| Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response C Bosi, Á Bartha, B Galbardi, G Notini, MM Naldini, L Licata, G Viale, ... European Journal of Cancer 195, 113379, 2023 | 8 | 2023 |
| A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis L Colleoni, B Galbardi, C Barzago, S Bonanno, S Franzi, R Frangiamore, ... Pharmacogenetics and Genomics 27 (2), 51-56, 2017 | 7 | 2017 |
| The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial T Triulzi, G Bianchini, S Di Cosimo, T Pienkowski, YH Im, GV Bianchi, ... Molecular oncology 16 (12), 2355-2366, 2022 | 6 | 2022 |
| Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial M Dugo, CS Huang, D Egle, B Bermejo, C Zamagni, RS Seitz, TJ Nielsen, ... Cancer Research 82 (4_Supplement), P2-07-12-P2-07-12, 2022 | 5 | 2022 |
| Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial M Dugo, CS Huang, D Egle, B Bermejo, C Zamagni, RS Seitz, TJ Nielsen, ... Cancer research 82 (4_Supplement), PD10-06-PD10-06, 2022 | 5 | 2022 |
| Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy L Licata, M Barreca, B Galbardi, M Dugo, G Viale, B Győrffy, T Karn, ... British Journal of Cancer 129 (12), 2025-2033, 2023 | 2 | 2023 |
| The CNS lymphatic system modulates the adaptive neuro-immune response in the perilesional cortex after brain trauma S Wojciechowski, M Vihma, B Galbardi, MH Keuters, S Antila, ... BioRxiv, 821645, 2019 | 2 | 2019 |
| Abstract PD10-09: Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines-or taxane-based treatment M Callari, M Barreca, M Dugo, B Galbardi, L Viganò, A Locatelli, L Licata, ... Cancer Research 82 (4_Supplement), PD10-09-PD10-09, 2022 | 1 | 2022 |
